Renaissance Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,156
Closed -$1.41M 281
2022
Q1
$1.41M Buy
19,156
+1,123
+6% +$78.1K 0.06% 138
2021
Q4
$1.3M Buy
18,033
+608
+3% +$44.1K 0.05% 149
2021
Q3
$1.33M Sell
17,425
-224
-1% -$18K 0.06% 126
2021
Q2
$1.37M Buy
17,649
+1,992
+13% +$142K 0.06% 124
2021
Q1
$966K Buy
15,657
+473
+3% +$30K 0.04% 170
2020
Q4
$990K Buy
15,184
+40
+0.3% +$2.3K 0.04% 150
2020
Q3
$750K Sell
15,144
-153
-1% -$7.89K 0.03% 160
2020
Q2
$730K Buy
15,297
+99
+0.7% +$4.78K 0.03% 156
2020
Q1
$646K Buy
15,198
+3,164
+26% +$156K 0.04% 148
2019
Q4
$709K Buy
12,034
+3,176
+36% +$172K 0.03% 203
2019
Q3
$453K Sell
8,858
-18
-0.2% -$857 0.02% 208
2019
Q2
$375K Sell
8,876
-421
-5% -$18.3K 0.02% 232
2019
Q1
$459K Sell
9,297
-484
-5% -$21.9K 0.02% 217
2018
Q4
$423K Buy
9,781
+428
+5% +$21.4K 0.02% 219
2018
Q3
$531K Buy
9,353
+508
+6% +$26.7K 0.02% 217
2018
Q2
$446K Sell
8,845
-1,296
-13% -$67.6K 0.02% 233
2018
Q1
$505K Sell
10,141
-1,460
-13% -$68.6K 0.02% 184
2017
Q4
$477K Buy
11,601
+9
+0.1% +$315 0.02% 190
2017
Q3
$345K Buy
11,592
+1
+0% +$31 0.01% 245
2017
Q2
$384K Buy
11,591
+277
+2% +$8.7K 0.01% 213
2017
Q1
$335K Sell
11,314
-121
-1% -$3.3K 0.01% 224
2016
Q4
$284K Buy
11,435
+26
+0.2% +$591 0.01% 249
2016
Q3
$258K Sell
11,409
-273
-2% -$6.42K 0.01% 253
2016
Q2
$278K Buy
11,682
+260
+2% +$6.24K 0.01% 226
2016
Q1
$271K Sell
11,422
-1,581
-12% -$38.6K 0.01% 240
2015
Q4
$362K Sell
13,003
-274
-2% -$6.88K 0.01% 162
2015
Q3
$274K Buy
13,277
+84
+0.6% +$2.13K 0.01% 224
2015
Q2
$339K Buy
13,193
+366
+3% +$9.27K 0.01% 177
2015
Q1
$324K Buy
12,827
+183
+1% +$4.46K 0.01% 187
2014
Q4
$301K Buy
12,644
+1,896
+18% +$42K 0.01% 180
2014
Q3
$211K Buy
10,748
+50
+0.5% +$1.03K 0.01% 251
2014
Q2
$256K Buy
+10,698
New +$258K 0.01% 232

Other funds holding GMED